1. Signaling Pathways
  2. Immunology/Inflammation
  3. CD3
  4. CD3 Ligand

CD3 Ligand

CD3 Ligand (1):

Cat. No. Product Name Effect Purity
  • HY-P991122
    Besufetamig
    Ligand
    Besufetamig is a bispecific antibody targeting programmed cell death 1 (PD-1) and CD3ε chain. Besufetamig modulates the activity of immune cells, exerting immunosuppressive and antineoplastic activities. Besufetamig is promising for research of cancers.